Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 2
1999 1
2000 1
2002 2
2003 2
2008 1
2010 1
2012 2
2013 1
2023 2
2024 7
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Why is pharmacovigilance essential for biosimilars?
Spini A, Bellitto C, Trifirò G. Spini A, et al. Among authors: bellitto c. Expert Opin Drug Saf. 2025 Nov 12:1-4. doi: 10.1080/14740338.2025.2588599. Online ahead of print. Expert Opin Drug Saf. 2025. PMID: 41216646 No abstract available.
Frequency of Biological Drug Use in Older Patients with Immune-Mediated Inflammatory Diseases: Results from the Large-Scale Italian VALORE Distributed Database Network.
Soardo F, Spini A, Pellegrini G, Costa G, Mathieu C, Bellitto C, L'Abbate L, Ingrasciotta Y, Leoni O, Zanforlini M, Ancona D, Stella P, Cavazzana A, Scapin A, Lopes S, Belleudi V, Ledda S, Carta P, Rossi P, Ejlli L, Sapigni E, Puccini A, Scarpelli RF, De Sarro G, Allotta A, Pollina SA, Da Cas R, Bucaneve G, Mangano AMP, Balducci F, Sorrentino C, Senesi I, Tuccori M, Gini R, Spila-Alegiani S, Massari M, Urru SAM, Campomori A, Trifirò G. Soardo F, et al. Among authors: bellitto c. BioDrugs. 2025 May;39(3):499-512. doi: 10.1007/s40259-025-00716-2. Epub 2025 Apr 3. BioDrugs. 2025. PMID: 40180772 Free PMC article.
Switching patterns of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network.
Spini A, Pellegrini G, Ingrasciotta Y, L'Abbate L, Bellitto C, Carollo M, Leoni O, Zanforlini M, Ancona D, Stella P, Cavazzana A, Scapin A, Lopes S, Belleudi V, Ledda S, Carta P, Rossi P, Ejlli L, Sapigni E, Puccini A, Spila Alegiani S, Massari M, Guarneri C, Gisondi P, Trifirò G. Spini A, et al. Among authors: bellitto c. Expert Opin Biol Ther. 2024 May;24(5):399-409. doi: 10.1080/14712598.2024.2357381. Epub 2024 May 21. Expert Opin Biol Ther. 2024. PMID: 38767132
Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities.
Crisafulli S, Ciccimarra F, Bellitto C, Carollo M, Carrara E, Stagi L, Triola R, Capuano A, Chiamulera C, Moretti U, Santoro E, Tozzi AE, Recchia G, Trifirò G. Crisafulli S, et al. Among authors: bellitto c. Front Drug Saf Regul. 2024 Mar 18;4:1356405. doi: 10.3389/fdsfr.2024.1356405. eCollection 2024. Front Drug Saf Regul. 2024. PMID: 40979393 Free PMC article. Review.
Trend in the use of biological drugs in pediatric patients with immune-mediated inflammatory diseases: Insight from the large-scale Italian VALORE project.
Bellitto C, Ingrasciotta Y, Soardo F, Spini A, L'Abbate L, Pellegrini G, Mathieu C, Carollo M, Tuccori M, Leoni O, Mazzone A, Ancona D, Stella P, Cavazzana A, Scapin A, Lopes S, Belleudi V, Ledda S, Carta P, Rossi P, Ejlli L, Sapigni E, Puccini A, Scarpelli RF, De Sarro G, Gini R, Allotta A, Pollina SA, Bucaneve G, Mangano AMP, Balducci F, Sorrentino C, Senesi I, Trama U, Bernardi FF, Da Cas R, Costa G, Urru SAM, Campomori A, Spila Alegiani S, Massari M, Gallizzi R, Trifirò G. Bellitto C, et al. Pharmacol Res. 2025 Aug;218:107843. doi: 10.1016/j.phrs.2025.107843. Epub 2025 Jun 28. Pharmacol Res. 2025. PMID: 40588108 Free article.
Single and multiple switches, swap and retransitioning among 28,073 biological drug users with inflammatory bowel diseases: results from the Italian VALORE network.
Pellegrini G, Spini A, Bellitto C, L'Abbate L, Ingrasciotta Y, Soardo F, Leoni O, Mazzone A, Ancona D, Stella P, Cavazzana A, Scapin A, Lopes S, Belleudi V, Ledda S, Carta P, Rossi P, Ejlli L, Sapigni E, Puccini A, Scarpelli RF, De Sarro G, Tuccori M, Gini R, Allotta A, Addario Pollina S, Da Cas R, Bucaneve G, Mangano AMP, Balducci F, Sorrentino C, Senesi I, Bernardi FF, Trama U, Spila Alegiani S, Mayer F, Massari M, Savarino EV, Variola A, Trifirò G. Pellegrini G, et al. Among authors: bellitto c. Therap Adv Gastroenterol. 2025 Sep 28;18:17562848251378080. doi: 10.1177/17562848251378080. eCollection 2025. Therap Adv Gastroenterol. 2025. PMID: 41030293 Free PMC article.
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials.
Ahmadizar F, Luxi N, Raethke M, Schmikli S, Riefolo F, Saraswati PW, Bucsa C, Osman A, Liddiard M, Maques FB, Petrelli G, Sonderlichová S, Thurin NH, Villalobos F, Trifirò G, Sturkenboom M; ilmiovaccinoCOVID19 collaborating group. Ahmadizar F, et al. Drug Saf. 2023 Jun;46(6):575-585. doi: 10.1007/s40264-023-01304-5. Epub 2023 Apr 27. Drug Saf. 2023. PMID: 37103643 Free PMC article.
Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study.
Raethke M, van Hunsel F, Luxi N, Lieber T, Bellitto C, Mulder E, Ciccimarra F, Riefolo F, Thurin NH, Roy D, Morton K, Villalobos F, Batel Marques F, Farcas A, Sonderlichová S, Belitser S, Klungel O, Trifirò G, Sturkenboom MC. Raethke M, et al. Among authors: bellitto c. Vaccine. 2024 Apr 2;42(9):2357-2369. doi: 10.1016/j.vaccine.2024.03.001. Epub 2024 Mar 6. Vaccine. 2024. PMID: 38448322 Free article.
Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy.
Ciccimarra F, Luxi N, Bellitto C, L' Abbate L, De Nardo P, Savoldi A, Yeomans A, Molokhia M, Tacconelli E, Trifirò G. Ciccimarra F, et al. Among authors: bellitto c. BioDrugs. 2023 Sep;37(5):675-684. doi: 10.1007/s40259-023-00601-w. Epub 2023 May 6. BioDrugs. 2023. PMID: 37148526 Free PMC article.
Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance Study.
Luxi N, Ciccimarra F, Bellitto C, Raethke M, van Hunsel F, Lieber T, Mulder E, L'Abbate L, Marques FB, Furci F, Farcas A, Giele-Eshuis J, Morton K, Sonderlichová S, Thurin NH, Villalobos F, Riefolo F, Sturkenboom MC, Trifirò G. Luxi N, et al. Among authors: bellitto c. Vaccines (Basel). 2024 Sep 17;12(9):1059. doi: 10.3390/vaccines12091059. Vaccines (Basel). 2024. PMID: 39340089 Free PMC article.
28 results